Britain’s National Health Service is losing a fight against the Bonkers Institute for Nearly Genuine Research — a web site that publicizes the underbelly of psychiatric medicine — over brochures for children that tell them how to take antipsychotic medicines such as Johnson & Johnson (JNJ)’s Risperdal (risperidone).
The U.S. Justice Department said that Johnson & Johnson’s kickbacks to Omnicare, the largest U.S. provider of pharmacy services to nursing homes, took multiple forms, including rebates that were conditioned on Omnicare engaging in an ‘Active Intervention Program’ for Risperdal and payments disguised as data purchase fees, educational grants, and fees to attend Omnicare meetings.
The journal Archives of General Psychiatry will “look into” whether an author who recommended antidepressants for preschoolers failed to disclose her financial ties to Johnson & Johnson, AstraZeneca and Shire, companies which make such drugs, according to Philip Dawdy of Furious Seasons.